Glycopyrrolate Inhalation Solution (GIS)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Glycopyrrolate Inhalation Solution (GIS), covering 2018-03-12 to 2018-03-12. Get the full timeline:
Most recent: Clinical Trial Update: Assessment of the Safety and Ability of a Once-a-day Dose of an Orally Inhaled Medicine [i.e., Glycopyrrolate Inhalation Solution = GIS] to Improve Airflow in the Lungs When Delivered Using an eFlow Nebulizer in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]